 Comparison sequential cyproterone acetate/estrogen spironolactone/oral contraceptive treatment hirsutism effects antiandrogen drugs cyproterone acetate CPA spironolactone hair growth androgen levels randomized study hirsute women Twenty subjects months therapy mg/day CPA subjects months mg/day spironolactone subjects concomitant estrogen therapy Measured total hair diameter spironolactone CPA diameter hair medulla spironolactone CPA difference drugs effect hair diameter Plasma testosterone levels drugs subjective assessment treatment efficacy frequency subjects cosmetic measures spironolactone CPA drugs difference drugs Side effects cessation treatment subject CPA subjects spironolactone side effects subjects treatment group spironolactone CPA dosages study effective tolerated agents treatment hirsutism drug particular advantage